Hi 4Earth,
On past form I don't think the company will take undue risks to meet the options expiry date (thank goodness).
From memory I think proof of concept was originally scheduled for about the time the *last* batch of options expired early this year. Then there was the Origin promise of $9 million if proof of concept came about by last March.
Now we've got another batch of options due to expire and we're still waiting on the same sorts of milestones - and at best it looks like it will be touch and go again for anyone holding them.
But on the bright side I can't see any outrageous risks being taken. There aren't a lot of these options anyway so in the grand scheme not a lot to lose. And if things go the right way for them regarding the tests, they will be in a better position to raise capital anyway (and probably issue more options along the way).
- Forums
- ASX - By Stock
- RNE
- short term pressure for gdy
short term pressure for gdy, page-2
-
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RNE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.727M |
Open | High | Low | Value | Volume |
0.1¢ | 0.1¢ | 0.1¢ | $400 | 400K |
Featured News
RNE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online